WuXi XDC Cayman's total inventories for the quarter that ended in Jun. 2023 was €6.1 Mil. WuXi XDC Cayman's average total inventories from the quarter that ended in Mar. 2023 to the quarter that ended in Jun. 2023 was €7.1 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. WuXi XDC Cayman's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was €0.01.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
WuXi XDC Cayman's Days Inventory for the
three
months ended in Jun. 2023 was 12.73.
Inventory Turnover measures how fast the company turns over its inventory within a year.
WuXi XDC Cayman's Inventory Turnover for the quarter that ended in Jun. 2023 was 7.17.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
WuXi XDC Cayman's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.11.
WuXi XDC Cayman Total Inventories Historical Data
The historical data trend for WuXi XDC Cayman's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
WuXi XDC Cayman (FRA:L74) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
WuXi XDC Cayman's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
WuXi XDC Cayman's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
WuXi XDC Cayman Total Inventories Related Terms
Thank you for viewing the detailed overview of WuXi XDC Cayman's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:L74 has been successfully added to your